Auditory stimuli as a trigger for arrhythmic events differentiate HERG- related (LQTS2) patients from KVLQT1-related patients (LQTS1)

Journal of the American College of Cardiology

Volumn 33, Issue 2, 1999, Pages 327-332

  Wilde, Arthur A M ^a,b,g   Jongbloed, Rosalie J E ^c,d   Doevendans, Pieter A ^c,d   Düren, Donald R ^a   Hauer, Richard N W ^b   Van Langen, Irene M ^a   Van Tintelen, J Peter ^e,f   Smeets, Hubert J M ^c   Meyer, Henk ^c   Geelen, Jan L M C ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e Clinical Genetics Center Utrecht   (Netherlands)

^f ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^g UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUDITORY STIMULATION; CHROMOSOME 11P; CHROMOSOME 21Q; CHROMOSOME 3P; CHROMOSOME 7Q; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE LOCATION; GENE MUTATION; GENETIC POLYMORPHISM; HEART ARREST; HEART VENTRICLE ARRHYTHMIA; HUMAN; LONG QT SYNDROME; MALE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SUDDEN DEATH;

ACOUSTIC STIMULATION; ADULT; AGED; AGED, 80 AND OVER; CATION TRANSPORT PROTEINS; DEATH, SUDDEN, CARDIAC; DISEASE PROGRESSION; DNA; DNA PROBES; DNA-BINDING PROTEINS; ELECTROCARDIOGRAPHY; ETHER-A-GO-GO POTASSIUM CHANNELS; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEART RATE; HUMANS; KCNQ POTASSIUM CHANNELS; KCNQ1 POTASSIUM CHANNEL; LONG QT SYNDROME; MALE; MUTATION; PHENOTYPE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; TRANS-ACTIVATORS;

EID: 0033081030     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00578-6     Document Type: Article

References (34)

1. Wellens H.J.J., Vermeulen A., Durrer D. Ventricular fibrillation occurring on arousal from sleep by auditory stimuli. Circulation. 46:1972;661-665.
2. Shimizu W., Ohe T., Kurita T., Tokuda T., Shimomura K. Epinephrine-induced ventricular premature complexes due to early afterdepolarizations and effects of verapamil and propranolol in a patient with congenital long QT syndrome. J Cardiovasc Electrophysiol. 5:1994;438-444.
3. Nakajima T., Misu K., Iwasawa K., et al. Auditory stimuli as a major cause of syncope in a patient with idiopathic long QT syndrome. Jpn Circ J. 59:1995;241-246.
4. Keating M.T., Atkinson D.L., Dunn C., Timothy K.W., Vincent G.M., Leppert M. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science. 252:1991;704-706.
5. Curran M.E., Splawski I., Timothy K.W., Vincent G.M., Green E.D., Keating M.T. A molecular basis for cardiac arrhythmia HERG mutations cause long QT syndrome. Cell. 80:1995;795-803.
6. Wang Q., Shen J., Splawski I., et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 80:1995;805-811.
7. Schott J.J., Charpentier F., Peltier S., et al. Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am J Hum Genet. 57:1995;1114-1122.
8. Wang Q., Curran M.E., Splawski I., et al. Positional cloning of a novel potassium channel gene KvLQT1 mutations cause cardiac arrhythmias. Nat Genet. 12:1996;17-23.
9. ks function. Nat Genet. 17:1997;338-340.
10. Kass R.S., Davies M.P. The roles of ion channels in an inherited heart disease molecular genetics of the long QT syndrome. Cardiovasc Res. 32:1996;443-454.
11. Roden D.M., Lazzara R., Rosen M., et al. Multiple mechanisms in the long QT syndrome. Current knowledge, gaps, and future directions. Circulation. 94:1996;1996-2012.
12. Moss A.J., Zareba W., Benhorin J., et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation. 92:1995;2929-2934.
13. Schultze-Bahr E., Haverkamp W., Breithardt G., Funke H., Wiebusch H., Assmann G. ECG repolarization patterns in chromosome 7-linked QT syndrome (LQTS 2). Circulation. 94:1996;2318-2319.
14. Schwartz PJ, Moss AJ, Priori SG, et al. Gene-specific influence on the triggers for cardiac arrest in the long QT syndrome [abstract]. Circulation 1997;96:I-212.
15. + channel blockade and to increases in heart rate. Circulation. 92:1995;3381-3386.
16. Müllerbach R., Lagoda P.J.L., Welter C. An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet. 5:1989;391.
17. Van den Berg M.H., Wilde A.A.M., Robles de Medina E.O., et al. The long QT syndrome a novel missense mutation in the S6 region of the KVLQT1 gene. Hum Genet. 100:1997;356-361.
18. Schwartz P.J., Moss A.J., Vincent G.M., Crampton R.S. Diagnostic criteria for the long QT syndrome an update. Circulation. 88:1993;782-784.
19. Vincent G.M., Timothy K.W., Leppert M., Keating M.T. The spectrum of symptoms and QT intervals in carriers of the gene for the long QT syndrome. N Engl J Med. 327:1992;846-852.
20. de Jager T., Corbett C.H., Badenhorst J.C.W., Brink P.A., Corfield V.A. Evidence of a long QT founder gene with varying phenotypic expression in South African families. J Med Genet. 33:1996;567-573.
21. Shimizu W., Antzelevitch C. Cellular basis for the electrocardiographic features of the LQT1 form of the long QT syndrome effects of β-adrenergic agonists, antagonists and sodium channel blockers on transmural dispersion of repolarization and torsades de pointes [abstract]. J Am Coll Cardiol. 31:1998;2A.
22. + channel blockade, β-adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long QT syndrome. Circ Res. 78:1996;1009-1015.
23. Shimizu W., Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsades de pointes in LQT2 and LQT3 models of the long QT syndrome. Circulation. 96:1997;2038-2047.
24. Viskin S., Alla S.R., Barron H.V., et al. Mode of onset of torsades de pointes in congenital long QT syndrome. J Am Coll Cardiol. 28:1996;1262-1268.
25. Dausse E., Berthet M., Denjoy I., et al. A mutation in HERG associated with notched T-waves in long QT syndrome. J Mol Cell Cardiol. 28:1996;1609-1615.
26. Timothy KW, Zhang L, Meyer KJ, Vincent GM. Differences in precipitators of cardiac arrest and sudden death in chromosome 11 versus 7 genotype long QT syndrome patients [abstract]. Circulation 1996;94:I-204.
27. Napolitano C, Priori SG, Schwartz PJ, et al. Identification in a mutational hot spot in HERG-related long QT syndrome (LQT2): phenotypic implications [abstract]. Circulation 1997;96:I-212.
28. Shimizu W., Ohe T., Kurita T., et al. Early afterdepolarizations induced by isoproterenol in patients with congenital long QT syndrome. Circulation. 84:1991;1915-1923.
29. +-channel dysfunction in an inherited cardiac arrhythmia. Proc Natl Acad Sci USA. 93:1996;2208-2212.
30. Sanguinetti M.C., Jurkiewicz N.K., Scott A., Siegl P.K.S. Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes mechanism of action. Circ Res. 68:1991;77-84.
31. + channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias. EMBO J. 16:1997;5472-5479.
32. + current, on repolarization in human and guinea pig ventricular myocytes. Cardiovasc Res. 38:1998;441-450.
33. + current in ventricular myocytes of the guinea pig type theoretical formulation and their role in repolarization. Circ Res. 77:1995;140-152.
34. + current in human ventricular myocytes. Circ Res. 78:1996;689-696.